Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals - Takeaways - MDSpire

Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals

  • By

  • Julian P. Struck

  • Maike Schnoor

  • Andrea Schulze

  • Marie C. Hupe

  • Tomasz Ozimek

  • Immanuel A. Oppolzer

  • Marco J. Schnabel

  • Maximilian Burger

  • Christopher Darr

  • Viktor Gruenwald

  • Boris Hadaschik

  • Maximilian Weinke

  • Hubert Kuebler

  • Jonas C. Klockenbusch

  • Markus T. Grabbert

  • Christian Gratzke

  • Mario W. Kramer

  • Alexander Katalinic

  • Axel S. Merseburger

  • November 30, 2021

  • 0 min

Share

  • 1

    The COVID-19 pandemic significantly impacted medical care for patients with metastatic uro-oncologic disease in German university hospitals.

  • 2

    Delays in systemic cancer therapy during the pandemic posed risks of disease progression and increased mortality for vulnerable uro-oncology patients.

  • 3

    A total of 162 patients receiving systemic anti-cancer treatment were included in the study, focusing on care changes during the first COVID-19 wave.

  • 4

    The study aimed to identify potential undertreatment and assess the influence of COVID-19 on urologic cancer care and patient prognosis.

  • 5

    Statistical analyses were conducted to evaluate associations between tumor entities, treatment modalities, and delays in follow-up care.

Original Source(s)

Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals

  • by Julian P. Struck, Maike Schnoor, Andrea Schulze, Marie C. Hupe, Tomasz Ozimek, Immanuel A. Oppolzer, Marco J. Schnabel, Maximilian Burger, Christopher Darr, Viktor Gruenwald, Boris Hadaschik, Maximilian Weinke, Hubert Kuebler, Jonas C. Klockenbusch, Markus T. Grabbert, Christian Gratzke, Mario W. Kramer, Alexander Katalinic, Axel S. Merseburger

  • November 30, 2021

Related Content

The impact of the COVID-19 pandemic on renal cancer care

COVID Vaccines: Ask The Experts with Dr. Anthony Fauci

Dr. Anthony Fauci and a panel of public health experts gathered live to discuss the COVID-19 pandemic in Florida and answer questions about the vaccines.

  • February 15, 2021

  • 1 min
COVID-19 and financial toxicity in patients with renal cell carcinoma